Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods  A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Helicobacter pylori infection and gastric carcinoma
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
R. Dumke, H. von Baum, P.C. Lück, E. Jacobs 
Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995–2001 
L. Boyanova  Clinical Microbiology and Infection 
Helicobacter pylori infection and gastric carcinoma
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
The use of AP-PCR and flaA-RFLP typing to investigate treatment failure in Helicobacter pylori infection  I. Adamsson, C. Edlund, R. Seensalu, L. Engstrand 
Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995–2001 
R. Cantón  Clinical Microbiology and Infection 
Genital Chlamydia trachomatis infections
A.E. Muller, U. Theuretzbacher, J.W. Mouton 
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure  Y.-C. Wang, Y.-T.
Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013  L.E.B. Nabarro, R.A. Lever, M. Armstrong,
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Phenotypic and molecular characterization of multidrug-resistant Salmonella enterica serovar Hadar in Greece, from 2007 to 2010  T. Papadopoulos, E. Petridou,
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi 
Impact of antibiotic restrictions: the pharmaceutical perspective
Vector control: a cornerstone in the malaria elimination campaign
Do we need new antibiotics?
L. Gatta, C. Ricci, A. Tampieri, D. Vaira 
Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients 
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Unexpectedly high prevalence of Treponema pallidum infection in the oral cavity of human immunodeficiency virus-infected patients with early syphilis.
Training for the infectious diseases speciality in Norway
G. Höffken  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community  R.E. Warren, G. Harvey, R. Carr, D. Ward,
S.-M. Sheu, B.-S. Sheu, C.-C. Lu, H.-B. Yang, J.-J. Wu 
Levofloxacin in the treatment of ventilator-associated pneumonia
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
Metagenomics and probiotics
M. Aires-de-Sousa  Clinical Microbiology and Infection 
Effect of antioxidants on the immune response of Helicobacter pylori
Previously unknown species of Aspergillus
Laboratory diagnosis of Clostridium difficile disease
N. Maggi-Solcà, C. Valsangiacomo, J.-C. Piffaretti 
T.M. File  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
Update on antifungal resistance in Aspergillus and Candida
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
Correlation between clinical data and antibiotic resistance in coagulase-negative Staphylococcus species isolated from 68 patients with acute post-cataract.
Clinical infection services—the Leiden experience
The use of AP-PCR and flaA-RFLP typing to investigate treatment failure in Helicobacter pylori infection  I. Adamsson, C. Edlund, R. Seensalu, L. Engstrand 
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Evaluation of the performance of the Helico Blot 2
Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013  A. Badura, G. Feierl, G. Pregartner,
M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo 
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Virology: a scientific discipline facing new challenges
Antibiotic resistance of Helicobacter pylori: a cross-sectional study in consecutive patients, and relation to ethnicity  R.J.L.F. Loffeld, C.A.P.M.J.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Great oaks from little acorns grow—21 years of CMI
Impact of antibiotic restrictions: the patient's perspective
CMI readers' survey Clinical Microbiology and Infection
Rajko Saletinger, Mario Poljak, Franc Strle 
The future of diagnostic bacteriology
Presentation transcript:

Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods  A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède, P. Lehours, F. Mégraud  Clinical Microbiology and Infection  Volume 22, Issue 8, Pages 715-718 (August 2016) DOI: 10.1016/j.cmi.2016.06.003 Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Evolution of primary clarithromycin resistance in Helicobacter pylori strains isolated from patients in France. Clinical Microbiology and Infection 2016 22, 715-718DOI: (10.1016/j.cmi.2016.06.003) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.